EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

ATG Plus Post-Transplantation Cyclophosphamide Improves EBV-DNA Clearance and GVHD in Patients of Adult Chronic Active Epstein-Barr Virus Disease Undergoing Allogeneic HSCT

Min Liu iD, Qiuxia Yu, Yang Cao, Yaxian Ma, Zetong Hong, Qing Yin, Yan Feng, Tongjuan Li, Yicheng Zhang, Miao Zheng

Journal of Blood Medicine · 2026-06 · Volume 17 · 1-12

DOI: 10.2147/jbm.s593133 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Blood Medicine, 2026-06. Verfasst von Min Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

anti-thymocyte globulinchronic active Epstein-Barr virus diseasegraft-versus-host diseasehematopoietic stem cell transplantationpost-transplant cyclophosphamide

Autor:innen und Institutionen

  • Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
  • Department of Hematology, Jingzhou Hospital, Affiliated to Yangtze University, Jingzhou, People's Republic of China.

ORCID-Profile: Min Liu

Zitieren

APA

Liu, M., Yu, Q., Cao, Y., Ma, Y., Hong, Z., Yin, Q., Feng, Y., Li, T., Zhang, Y., & Zheng, M. (2026). ATG Plus Post-Transplantation Cyclophosphamide Improves EBV-DNA Clearance and GVHD in Patients of Adult Chronic Active Epstein-Barr Virus Disease Undergoing Allogeneic HSCT. Journal of Blood Medicine, Volume 17, 1-12. https://doi.org/10.2147/jbm.s593133

Vancouver

Liu M, Yu Q, Cao Y, Ma Y, Hong Z, Yin Q, et al. ATG Plus Post-Transplantation Cyclophosphamide Improves EBV-DNA Clearance and GVHD in Patients of Adult Chronic Active Epstein-Barr Virus Disease Undergoing Allogeneic HSCT. Journal of Blood Medicine. 2026;Volume 17:1-12. doi:10.2147/jbm.s593133

BibTeX
@article{Liu2026,
  author = {Liu, Min and Yu, Qiuxia and Cao, Yang and Ma, Yaxian and Hong, Zetong and Yin, Qing and Feng, Yan and Li, Tongjuan and Zhang, Yicheng and Zheng, Miao},
  title = {ATG Plus Post-Transplantation Cyclophosphamide Improves EBV-DNA Clearance and GVHD in Patients of Adult Chronic Active Epstein-Barr Virus Disease Undergoing Allogeneic HSCT},
  journal = {Journal of Blood Medicine},
  year = {2026},
  volume = {Volume 17},
  pages = {1--12},
  doi = {10.2147/jbm.s593133}
}
Kostenlos starten →